Literature DB >> 23645142

Combining self-help and professional help to minimize barriers to physical activity in persons with multiple sclerosis: a trial of the "Blue Prescription" approach in New Zealand.

Hilda Mulligan1, Gareth J Treharne, Leigh A Hale, Cath Smith.   

Abstract

BACKGROUND AND
PURPOSE: Increasing participation in physical activity is a goal for many health care providers working with persons with disability. In order to reduce the physical and social barriers to participation, there is a need to develop approaches that integrate self-help with professional help for autonomous yet supported health promotion. This study reports on an innovative program, entitled the "Blue Prescription approach", in which physical therapists work collaboratively with persons with a disability to promote community-based physical activity participation.
METHODS: We trialed this collaborative approach with two physical therapists and 27 participants with multiple sclerosis (MS) over a three month period. We gathered qualitative data from four sources: (i) individual interviews with our participants, (ii) individual interviews with the physical therapists, (iii) clinical notes, and (iv) Advisory Group meeting notes. We then analyzed these data for categories to inform the content and resources required for delivery of the approach.
RESULTS: For most participants, the Blue Prescription approach facilitated regular engagement in the physical activity of their choice. The Advisory Group provided advice to help solve individual contexts that presented as challenges to participants. Based on review of interview transcripts, we identified four strategies or issues to inform the further development of Blue Prescription. DISCUSSION AND
CONCLUSIONS: Evidence indicated that the Blue Prescription approach can provide a collaborative and flexible way for physical therapists to work with individuals with MS, to increase participation in community-based physical activity. To further develop the approach, there is a need to address issues related to the use of standardized measures and develop strategies to train physical therapists in collaborative approaches for promotion of physical activity.The integration of self-help and professional help provided by the Blue Prescription approach appeared to result in successful promotion of physical activity in persons with MS. Additional testing is required to examine its efficacy in other health care systems, in conditions beyond MS, and in terms of its economic impact.Video Abstract available (see Video, Supplemental Digital Content 1, http://links.lww.com/JNPT/A46) for more insights from the authors.

Entities:  

Mesh:

Year:  2013        PMID: 23645142     DOI: 10.1097/NPT.0b013e318292799e

Source DB:  PubMed          Journal:  J Neurol Phys Ther        ISSN: 1557-0576            Impact factor:   3.649


  4 in total

Review 1.  From Disease to Health: Physical Therapy Health Promotion Practices for Secondary Prevention in Adult and Pediatric Neurologic Populations.

Authors:  Lori Quinn; Don Morgan
Journal:  J Neurol Phys Ther       Date:  2017-07       Impact factor: 3.649

2.  Attitudes and barriers to exercise in adults with type 1 diabetes (T1DM) and how best to address them: a qualitative study.

Authors:  Nadia Lascar; Amy Kennedy; Beverley Hancock; David Jenkins; Robert C Andrews; Sheila Greenfield; Parth Narendran
Journal:  PLoS One       Date:  2014-09-19       Impact factor: 3.240

3.  Flipping the ICF: Exploring the Interplay of Theory and the Lived Experience to Reconsider Physical Activity in Community-Dwelling People With Multiple Sclerosis.

Authors:  Andrea Marjorie Stennett; Lorraine H De Souza; Meriel Norris
Journal:  Front Rehabil Sci       Date:  2021-10-01

4.  Development and Delivery of a Physical Activity Intervention for People With Huntington Disease: Facilitating Translation to Clinical Practice.

Authors:  Lori Quinn; Rob Trubey; Nina Gobat; Helen Dawes; Rhiannon Tudor Edwards; Carys Jones; Julia Townson; Cheney Drew; Mark Kelson; Vincent Poile; Anne Rosser; Kerenza Hood; Monica Busse
Journal:  J Neurol Phys Ther       Date:  2016-04       Impact factor: 4.655

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.